Pipra

Our mission: to tackle a fundamental, unmet challenge in healthcare;Post-Operative Delirium (POD) with a proprietary A.I-driven risk assessment tool to help doctors find patients at risk prior to surgery. Our SaaS software uses the largest, richest database in the world (which we own) to drive its algorithm. POD can have dramatic adverse outcomes on patients including doubling nursing care admissions and a dramatic increase in mortality. POD also has significant increases in costs to the hospital, insurance company and society at large which we can help reduce. We received CE certification as a medical device and currently launching in several hospitals in Switzerland, Germany and The Netherlands. Our pre-seed funding came from EIT Health.
Our vision: to become a category leader in reducing delirium. Delirium in totality has a higher cost burden to healthcare than diabetes and POD is the first product and focus.